All posts by Arthritis Foundation

New York Arthritis Biosimilars

New York Step Therapy Reform Legislation Signed into Law by Governor Cuomo

As we ring in the new year, we celebrate a major step therapy legislative win in New York! An increasing number of health insurers around the country are utilizing fail first or step therapy practices that require patients to try and fail one or more formulary medications before providing coverage for the originally prescribed non-formulary medication. Rather than taking into account the needs of the individual patient, insurers are determining drug sequences based on cost. These practices can vary wildly insurer to insurer with no consistency on how to establish or apply these fail first protocols.
Continue reading New York Step Therapy Reform Legislation Signed into Law by Governor Cuomo

Medicare Part B Demonstration Proposal Withdrawn

Victory – Medicare Part B Demonstration Proposal Withdrawn!

Arthritis Advocate Medicare Part B Demonstration Proposal
Arthritis Foundation Advocate, Amy Barron, along with Senator Rob Portman (R-OH).

Amy Barron lives with rheumatoid arthritis and osteoporosis. Her treatment includes biologic infusions that are administered under careful supervision by her physician. When Amy receives her infusion, she is in a familiar environment – her rheumatologist’s office – and her care is supervised by someone who knows her unique medical history, understands the complicated nature of her condition and can monitor her treatment and knowingly respond to adverse reactions.
Continue reading Victory – Medicare Part B Demonstration Proposal Withdrawn!

Ohio Arthritis Biosimilars

Ohio Biosimilar Substitution bill signed into Law by Governor Kasich

Imagine that your pharmacist substituted the biologic drug prescribed by your physician for a different drug, an interchangeable biologic product, without your physician being informed. For many people in Ohio who are taking biologic drugs, this scary scenario was a potential reality.
Continue reading Ohio Biosimilar Substitution bill signed into Law by Governor Kasich

21st Century Cures Act Signed into Law

President Obama Signs 21st Century Cures Act Into Law

obama-21st-century-curesDescribing it as “…an opportunity to save lives, an opportunity we just can’t miss,” President Barack Obama signed the 21st Century Cures Act into law earlier today.

As we shared with you just last week, the Act recently passed the House of Representatives and the Senate after years of work at the ground level to make its passage today a reality.
Continue reading President Obama Signs 21st Century Cures Act Into Law

Arthritis Patients Access Treatment

Arthritis Foundation Meets with Centers for Medicare and Medicaid Services & America’s Health Insurance Plans to Continue the Fight in Improving Patient Access

Our work in identifying and addressing issues that are affecting your access to care and drug costs continued this past month as we met with the Centers for Medicare and Medicaid Services (CMS), and America’s Health Insurance Plans (AHIP).
Continue reading Arthritis Foundation Meets with Centers for Medicare and Medicaid Services & America’s Health Insurance Plans to Continue the Fight in Improving Patient Access

Medicare Part B Demonstration Proposal Withdrawn

21st Century Cures Act Passes House of Representatives – A Big Win for the Arthritis Community

Thanks in large part to the hard work of our Advocates, the 21st Century Cures Act passed the House of Representatives on Nov. 30, clearing a major hurdle as the bill moves closer to enactment. If enacted, this comprehensive bill will improve access to life-changing care through several initiatives including: Continue reading 21st Century Cures Act Passes House of Representatives – A Big Win for the Arthritis Community

barriers arthritis care

Arthritis Advocate Gives Patient Perspective on Access to Care at Congressional Briefing

For 14 years, Elizabeth Krempley has lived with rheumatoid arthritis (RA). She has also lived with the difficulty of affording the high cost of her medications and the burden of getting her medications covered by insurers. She has not always been able to take her drugs as a result of those difficulties, resulting in adverse health consequences.
Continue reading Arthritis Advocate Gives Patient Perspective on Access to Care at Congressional Briefing

Arthritis Industry Forum

Patient Voice Has Strong Representation at 2016 Arthritis Industry Forum

Representatives from the employee benefits and pharmaceutical fields convened with members of the arthritis patient community, Arthritis Foundation and the federal government in Washington, DC, on October 5-6, 2016, to discuss issues related to arthritis patient barriers to health care. The two-day event featured insightful presentations from industry experts covering topics from how employers make employee benefit decisions to the evolution of healthcare reform.
Continue reading Patient Voice Has Strong Representation at 2016 Arthritis Industry Forum

Advocate for Arthritis August Recess

Arthritis Advocates Meet with Members of Congress During August Recess: Push for Support of the Ensuring Access to Children’s Specialty Care Act

Every summer Congress takes a break and each member of Congress departs Washington, D.C. for their home district. This break dates back to a time when most members of Congress had other responsibilities back home, most notably returning to their farms for harvest. The break, often referred to as August Recess, has evolved into an opportunity for the members to head home and meet with their constituents.
Continue reading Arthritis Advocates Meet with Members of Congress During August Recess: Push for Support of the Ensuring Access to Children’s Specialty Care Act